MPN News From ASH 2017: Headlines and Updates From an Expert Panel

Published on

Topics include: Treatment and Understanding

As part of our coverage from the 2017 American Society of Hematology (ASH) annual meeting, A “super panel” of MPN experts Dr. Mark Heaney, Dr. Rami Komrokji, Dr. Ruben Mesa, Dr. Jamile Shammo, as well as Andrew Schorr, gathered to discuss the latest news and developments related to research and treatment of myeloproliferative neoplasms (MPNs). The experts all shared their perspective on the “headlines” from this year’s meeting, including updates on JAK inhibitors in development, news on interferon, diagnostic testing, the story that somatic mutations tell, and the overwhelming interest in the study of MPNs.  Watch to learn the latest news in MPN research.

Sponsored by Incyte Corporaton.

View more programs featuring , , , and

Related Programs

ASH 2017 Daily Wrap: Day One

Patient Power founders Andrew and Esther Schorr are joined by MPN expert Dr. Naveen Pemmaraju, as they discuss research news from the 2017 ASH meeting.

Published:

Patient Engagement: Educating Yourself to Access Better MPN Care

Where can newly diagnosed MPN patients go to get informed and feel connected? Watch now to find out about available MPN tools and resources.

Published:

Is There a Role for CAR-T Cell Therapy in MPNs?

Dr. Abdulraheem Yacoub explains how CAR-T cell therapy targets cancer cells in the body and what the future holds for this treatment method.

Published:

Advertisement
Join Our Community Register For Events Read Our Latest Blog
Advertisement

Page last updated on January 23, 2018